title: Is administration of gadolinium-based contrast media to pregnant women and small children justified?
abstract: The use of gadolinium-based contrast media in pregnant or lactating women has been discouraged at many radiology departments due to the lack of knowledge of the risks for the fetus and the unwillingness to expose neonates to unnecessary drugs. In the present review the current literature and present guidelines regarding the use of gadolinium-based contrast media have been reviewed to validate the justification for their administration to pregnant or lactating women and small children.
authors.affiliation: Centre for Medical Imaging and Physiology, Skåne University Hospital, Lund University, Lund, Sweden. pia.sundgren@med.lu.se
authors.forename: Pia C
authors.initials: PC
authors.lastname: Sundgren
authors.forename: Peter
authors.initials: P
authors.lastname: Leander
mesh_terms: D000328:Adult; D000367:Age Factors; D000818:Animals; D002675:Child, Preschool; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D005682:Gadolinium / Q000008:administration & dosage / Q000009:adverse effects*; D005865:Gestational Age; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007774:Lactation / Q000187:drug effects*; D008279:Magnetic Resonance Imaging / Q000009:adverse effects / Q000379:methods; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced / Q000503:physiopathology; D011270:Pregnancy, Animal; D011817:Rabbits; D011856:Radiographic Image Enhancement / Q000379:methods; D015203:Reproducibility of Results; D018570:Risk Assessment; D017751:Safety Management; D013548:Sweden
chemical_list: D003287:Contrast Media; D005682:Gadolinium